Is procalcitonin a diagnostic and/or prognostic marker in sepsis?

Infectious Diseases in Clinical Practice

Volumn 23, Issue 1, 2015, Pages 3-6

  Afsar, Ilhan ^a   Sener, Asli Gamze ^a  

^a ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Procalcitonin; sepsis

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; PROCALCITONIN;

ANTIBIOTIC THERAPY; BACTERIAL INFECTION; DISEASE SEVERITY; HUMAN; INTENSIVE CARE UNIT; LABORATORY TEST; LEUKOCYTE COUNT; MORTALITY; PROGNOSIS; PROTEIN BLOOD LEVEL; REVIEW; SEPSIS; SURVIVOR;

EID: 84920876698     PISSN: 10569103     EISSN: 15369943     Source Type: Journal    
DOI: 10.1097/IPC.0000000000000187     Document Type: Review

References (42)

1. Kibe S, Adams K, Barlow G. Diagnostic and prognostic biomarkers of sepsis in critical care. J Antimicrob Chemother. 2011;66:33-40.
2. Aikawa N, Fujishima S, Endo S, et al. Multicenter prospective study of procalcitonin as an indicator of sepsis. J Infect Chemother. 2005;11:152-159.
3. Kim MH, Lim G, Kang SY, et al. Utility of procalcitonin as an early diagnostic marker of bacteremia in patients with acute fever. Yonsei Med J. 2011;52:276-281.
4. Weinstein MP, Doern GV. A critical appraisal of the role of the clinical microbiology laboratory in the diagnosis of bloodstream infections. J Clin Microbiol. 2011;49:26-29.
5. Scuetz P, Christ-Crain M, Muller B. Procalcitonin and other biomarkers for the assessment of disease severity and guidance of treatment in bacterial infections. Adv Sepsis. 2008;6:82-89.
6. Peters RP, van Agtmael MA, Danner SA, et al. New developments in the diagnosis of bloodstream infections. Lancet Infect Dis. 2004;4:751-760.
7. Edmond MB, Wallace SE, McClish DK, et al. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis. 1999;29:239-244.
8. Jin M, Khan AI. Procalcitonin: uses in the clinical laboratory for the diagnosis of sepsis. Lab Med. 2010;41:173-177.
9. Muller B, Becker KL. Procalcitonin: how a hormone became a marker and mediator of sepsis. Swiss Med Wkly. 2001;131:595-602.
10. Le Moullec JM, Jullienne A, Chenais J, et al. The complete sequence of human procalcitonin. FEBS Lett. 1984;167:93-97.
11. Müller B, White JC, Nylén ES, et al. Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab. 2001;86:396-404.
12. Becker K, Moller B, Nylen E, et al. Calcitonin gene family of peptides. In: K, ed. Principles and Practise of Endocrinology and Metablosm. Philadelphia, PA: Lippincott; 2001:520-534.
13. Schuetz P, Christ-Crain M, Müller B. Procalcitonin and other biomarkers to improve assessment and antibiotic stewardship in infections-hope for hype? Swiss Med Wkly. 2009;139:318-326.
14. Christ-Crain M, Müller B. Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators. Eur Respir J. 2007;30:556-573.
15. Assicot M, Gendrel D, Garsin H, et al. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993;341: 515-518.
16. Gendrel D, Bouon C. Procalcitonin, a marker of bacterial infection. Infection. 1997;25:133-134.
17. Dandona P, Nix D, Wilson MF, et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab. 1994;79: 1605-1608.
18. Rowther FB, Rodrigues CS, Deshmukh MS, et al. Prospective comparison of eubacterial PCR and measurement of procalcitonin levels with blood culture for diagnosing septicemia in intensive care unit patients. J Clin Microbiol. 2009;47:2964-2969.
19. Charles PE, Ladoire S, Aho S, et al. Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either Gram negative or Gram positive bacteria. BMC Infect Dis. 2008;8:38.
20. Harbarth S, Holeckova K, Froidevaux C, et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med. 2001;164:396-402.
21. Riedel S, Melendez JH, An AT, et al. Procalcitonin as a marker for the detection of bacteremia and sepsis in the emergency department. Am J Clin Pathol. 2011;135:182-189.
22. Kouhpayeh H, Hashemi M, Naderi M, et al. The status of serum procalcitonin in sepsis and non-infectious systemic inflammatory response syndrome. Afr J Microbiol Res. 2010;4:2632-2634.
23. Laupland KB, Church DL, Gregson DB. Blood cultures in ambulatory outpatients. BMC Infect Dis. 2005;5:35.
24. Lee H. Procalcitonin as a biomarker of infectious diseases. Korean J Intern Med. 2013;28:285-291.
25. Casado-Flores J, Blanco-Quirós A, Asensio J, et al. Serum procalcitonin in children with suspected sepsis: a comparison with C-reactive protein and neutrophil count. Pediatr Crit Care Med. 2003;4:190-195.
26. Uzzan B, Cohen R, Nicolas P, et al. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med. 2006;34:1996-2003.
27. Nylen ES, Whang KT, Snider RH Jr, et al. Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Crit Care Med. 1998;26:1001-1006.
28. Steinwald PM, Whang KT, Becker KL, et al. Elevated calcitonin precursor levels are related to mortality in an animal model of sepsis. Crit Care. 1999;3:11-16.
29. Dahaba AA, Metzler H. Procalcitonin's role in the sepsis cascade. Is procalcitonin a sepsis marker or mediator? Minerva Anestesiol. 2009;75: 447-452.
30. Hatzistilianou M, Rekleity A, Athanassiadou F, et al. Serial procalcitonin responses in infection of children with secondary immunodeficiency. Clin Invest Med. 2007;30:75-85.
31. Hatzistilianou M, Rekliti A, Athanassiadou F, et al. Procalcitonin as an early marker of bacterial infection in neutropenic febrile children with acute lymphoblastic leukemia. Inflamm Res. 2010;59:339-347.
32. Schuetz P, Chiappa V, Briel M, et al. Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms. Arch Intern Med. 2011;171:1322-1331.
33. Karlsson S, Heikkinen M, Pettilä V, et al. Predictive value of procalcitonin decrease in patients with severe sepsis: a prospective observational study. Crit Care. 2010;14:205.
34. Becker KL, Snider R, Nylen ES. Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target. Br J Pharmacol. 2010;159:253-264.
35. Lopez FRE, Jimenez AER, Tobon GC, et al. Procalcitonin (PCT), C reactive protein (CRP) and its correlation with severity in early sepsis. Clin Rev Opin. 2011;3:26-31.
36. Giamarellos-Bourboulis EJ, Mega A, Grecka P, et al. Procalcitonin: a marker to clearly differentiate systemic inflammatory response syndrome and sepsis in the critically ill patient? Intensive Care Med. 2002;28: 1351-1356.
37. Schuetz P, Albrich W, Mueller B. Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future. BMC Med. 2011;9:107.
38. Sinha M, Desai S, Mantri S, et al. Procalcitonin as an adjunctive biomarker in sepsis. Indian J Anaesth. 2011;55:266-270.
39. Papadopoulos A, Bartziokas K, Kostikas K. The role of Procalcitonin in the management of patients with sepsis and respiratory tractinfections: from bench to bedside. Pneumon. 2010;23:369-375.
40. Bouadma L, Luyt CE, Tubach F, et al. PRORATA trial group. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet. 2010;375:463-744.
41. Quenot JP, Luyt CE, Roche N, et al. Role of biomarkers in the management of antibiotic therapy: an expert panel review II: clinical use of biomarkers for initiation or discontinuation of antibiotic therapy. Ann Intensive Care. 2013;3:21.
42. Wacker C, Prkno A, Brunkhorst FM, et al. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13:426-435.